Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY, the companies COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021.
- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY, the companies COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021.
- This announcement is a result of the European Commissions decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020 .
- The additional 100 million doses will be delivered in 2021 supporting the vaccination campaigns which started two days ago in all 27 member states.
- Pfizer and BioNTech announced on November 11, 2020, that they reached an agreement with the European Commission to supply 200 million doses, with an option for the European Commission to request an additional 100 million doses.